{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:17:42Z","timestamp":1778671062638,"version":"3.51.4"},"reference-count":59,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100011033","name":"MEC | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["RTI2018-100903-B-I00"],"award-info":[{"award-number":["RTI2018-100903-B-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"MEC | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-125660OB-I00"],"award-info":[{"award-number":["PID2021-125660OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educacion, Cultura y Deporte","doi-asserted-by":"crossref","award":["FPU18\/01559"],"award-info":[{"award-number":["FPU18\/01559"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educacion, Cultura y Deporte","doi-asserted-by":"crossref","award":["FPU19\/04169"],"award-info":[{"award-number":["FPU19\/04169"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2023,5,17]]},"abstract":"<jats:p>Clorsulon is a benzenesulfonamide drug that is effective in treating helminthic zoonoses such as fascioliasis. When used in combination with the macrocyclic lactone ivermectin, it provides high broad-spectrum antiparasitic efficacy.<\/jats:p>","DOI":"10.1128\/aac.00095-23","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:00:18Z","timestamp":1681999218000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Role of the Abcg2 Transporter in Secretion into Milk of the Anthelmintic Clorsulon: Interaction with Ivermectin"],"prefix":"10.1128","volume":"67","author":[{"given":"Esther","family":"Blanco-Paniagua","sequence":"first","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas-Fisiolog\u00eda, Facultad de Veterinaria, Universidad de Le\u00f3n, Le\u00f3n, Spain"},{"name":"Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de Le\u00f3n, Le\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"\u00c1lvarez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas-Fisiolog\u00eda, Facultad de Veterinaria, Universidad de Le\u00f3n, Le\u00f3n, Spain"},{"name":"Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de Le\u00f3n, Le\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Rodr\u00edguez-Alonso","sequence":"additional","affiliation":[{"name":"Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de Le\u00f3n, Le\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Mill\u00e1n-Garcia","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas-Fisiolog\u00eda, Facultad de Veterinaria, Universidad de Le\u00f3n, Le\u00f3n, Spain"},{"name":"Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de Le\u00f3n, Le\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas-Fisiolog\u00eda, Facultad de Veterinaria, Universidad de Le\u00f3n, Le\u00f3n, Spain"},{"name":"Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de Le\u00f3n, Le\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-3475","authenticated-orcid":true,"given":"Gracia","family":"Merino","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas-Fisiolog\u00eda, Facultad de Veterinaria, Universidad de Le\u00f3n, Le\u00f3n, Spain"},{"name":"Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de Le\u00f3n, Le\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00828-10"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00012-09"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2010.05.013"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S332378"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2011.11.030"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2018.05.005"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2005.10.008"},{"key":"e_1_3_2_9_2","volume-title":"European public MRL assessment report (EPMAR). Clorsulon. Cattle.","author":"Committee for Medicinal Products for Veterinary Use, European Medicines Agency","year":"2008","unstructured":"Committee for Medicinal Products for Veterinary Use, European Medicines Agency. 2008. European public MRL assessment report (EPMAR). Clorsulon. Cattle. EMEA\/CVMP\/358525\/2008. European Medicines Agency, Amsterdam, The Netherlands."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/tvjl.1999.0377"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.159.13.424"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13567-019-0710-7"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-013-3321-7"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1107\/S2059798322000079"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/expr.2000.4501"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.14202\/vetworld.2016.1233-1237"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-4017(01)00460-5"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2001.218.1465"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1992.tb01018.x"},{"key":"e_1_3_2_20_2","volume-title":"Clorsulon.","author":"Committee for Veterinary Medicinal Products, European Agency for the Evaluation of Medicinal Products","year":"1995","unstructured":"Committee for Veterinary Medicinal Products, European Agency for the Evaluation of Medicinal Products. 1995. Clorsulon. EMEA\/MRL\/037\/95-FINAL. European Agency for the Evaluation of Medicinal Products, Amsterdam, The Netherlands."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.h6287"},{"key":"e_1_3_2_22_2","volume-title":"European public MRL assessment report (EPMAR). Clorsulon (bovine milk)\u2014after the provisional maximum residue limit (MRL).","author":"Committee for Medicinal Products for Veterinary Use, European Medicines Agency","year":"2014","unstructured":"Committee for Medicinal Products for Veterinary Use, European Medicines Agency. 2014. European public MRL assessment report (EPMAR). Clorsulon (bovine milk)\u2014after the provisional maximum residue limit (MRL). EMA\/CVMP\/752339\/2013. European Medicines Agency, Amsterdam, The Netherlands."},{"key":"e_1_3_2_23_2","volume-title":"Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits.","author":"European Medicines Agency","year":"2014","unstructured":"European Medicines Agency. 2014. Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits. EMA\/CVMP\/741367\/2013-Rev1. European Medicines Agency, Amsterdam, The Netherlands."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1021\/jf00087a054"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920112800399121"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102372"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13302-2"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.08.007"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/19440049.2014.908261"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.11.007"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2006.00744.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2010.01241.x"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2012.09.012"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-018-1341-3"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2013.07.033"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.022715"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apar.2018.08.002"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06345-11"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666180201094730"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.003319"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-4062"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00062-22"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22262"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-003-0863-0"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9632-1"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/ani11102758"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.2307\/3280917"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.2307\/3280320"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1186"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.008219"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.010439"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.118.085506"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113924"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2017.06.038"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.055970"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0208-5"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2022.10.019"},{"key":"e_1_3_2_58_2","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen JD","year":"2002","unstructured":"Allen JD, van Loevezijn A, Lakhai JM, van der Valk M, van Tellingen O, Reid G, Schellens JHM, Koomen G-J, Schinkel AH. 2002. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther 1:417\u2013425.","journal-title":"Mol Cancer Ther"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202607599"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2004.04.001"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00095-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00095-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T13:07:05Z","timestamp":1684328825000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00095-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,17]]}},"alternative-id":["10.1128\/aac.00095-23"],"URL":"https:\/\/doi.org\/10.1128\/aac.00095-23","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"2023-01-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00095-23"}}